Share Price and Basic Stock Data
Last Updated: December 12, 2025, 6:15 am
| PEG Ratio | 2.75 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cera Sanitaryware Ltd operates in the ceramics and sanitaryware industry, a sector that has shown resilience amidst fluctuating market conditions. As of March 2025, the company reported revenues of ₹1,915 Cr, a steady increase from ₹1,803 Cr in the previous fiscal year. This growth trajectory is indicative of a robust demand for sanitary products, especially in the residential and commercial construction sectors. The company’s quarterly sales figures also reflect this momentum, with the last reported quarter in March 2025 showing a sales figure of ₹578 Cr, marking a recovery from the preceding quarter’s ₹419 Cr. This upward trend in sales suggests that Cera is effectively capitalizing on the growing urbanization and infrastructure development in India, which are crucial drivers for the ceramics market.
Profitability and Efficiency Metrics
Profitability remains a strong suit for Cera Sanitaryware, as evidenced by its net profit of ₹246 Cr for the fiscal year 2025, up from ₹210 Cr in the prior year. This reflects a commendable profit margin of approximately 12.91%, which is above the industry average, signaling efficient cost management and pricing strategies. The operating profit margin (OPM) stood at 15% for FY 2025, consistent with previous years, indicating that the company has maintained its operational efficiency despite rising input costs. Furthermore, Cera’s return on equity (ROE) of 18.3% and return on capital employed (ROCE) of 22.4% demonstrate its effective utilization of shareholder funds and capital resources, respectively, positioning it favorably against peers in the sector.
Balance Sheet Strength and Financial Ratios
Cera Sanitaryware’s balance sheet reflects a solid financial foundation, with total borrowings reported at just ₹60 Cr against reserves of ₹1,364 Cr. This low debt level translates to a comfortable debt-to-equity ratio, reinforcing the company’s financial stability. The interest coverage ratio (ICR) of 48.10x further emphasizes its ability to meet interest obligations comfortably, showcasing strong cash generation capabilities. Additionally, the current ratio of 3.82 indicates a healthy liquidity position, suggesting that Cera is well-prepared to handle short-term liabilities. However, the increasing cash conversion cycle, which rose to 137 days in FY 2025, may indicate challenges in managing working capital effectively, necessitating closer monitoring to ensure operational efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cera Sanitaryware illustrates a balanced distribution of ownership, with promoters holding 54.41% of the shares, which reflects strong management control. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have a combined stake of around 29.38%, indicating significant institutional interest. However, the slight decline in FII holdings from 20.92% in September 2023 to 15.83% in September 2025 could raise concerns about investor sentiment. Conversely, the increase in public shareholding suggests growing retail investor confidence. The total number of shareholders has also seen fluctuations, currently standing at 1,47,987, highlighting a diverse investor base that could provide stability during market volatilities.
Outlook, Risks, and Final Insight
Looking ahead, Cera Sanitaryware appears well-positioned to leverage the growth in the Indian sanitaryware market, driven by urbanization and rising disposable incomes. However, rising raw material costs and potential supply chain disruptions present risks that could impact margins. The company’s ability to navigate these challenges will be crucial in maintaining profitability. Furthermore, while the strong balance sheet offers a buffer against economic downturns, any significant downturn in the real estate sector could adversely affect demand for its products. Investors should weigh these factors carefully, considering both the strengths of Cera’s operational performance and the potential headwinds. Overall, while the company exhibits strong fundamentals, a prudent approach is advised, keeping an eye on market dynamics and operational efficiency.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cera Sanitaryware Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Exxaro Tiles Ltd | 358 Cr. | 8.00 | 11.5/5.22 | 67.3 | 6.21 | 0.00 % | 3.49 % | 0.26 % | 1.00 |
| Carysil Ltd | 2,674 Cr. | 940 | 1,072/482 | 33.0 | 199 | 0.26 % | 15.4 % | 14.5 % | 2.00 |
| Somany Ceramics Ltd | 1,720 Cr. | 419 | 706/395 | 30.1 | 191 | 0.72 % | 11.5 % | 8.17 % | 2.00 |
| Orient Bell Ltd | 396 Cr. | 270 | 350/215 | 60.5 | 217 | 0.19 % | 2.38 % | 0.90 % | 10.0 |
| Nitco Ltd | 2,015 Cr. | 88.0 | 164/76.5 | 13.2 | 0.00 % | 42.9 % | % | 10.0 | |
| Industry Average | 3,569.33 Cr | 816.15 | 40.10 | 200.53 | 0.47% | 12.44% | 14.63% | 6.10 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 396 | 414 | 456 | 533 | 427 | 461 | 437 | 547 | 398 | 490 | 449 | 578 | 419 |
| Expenses | 335 | 348 | 383 | 445 | 358 | 387 | 377 | 455 | 342 | 420 | 390 | 472 | 366 |
| Operating Profit | 61 | 66 | 73 | 88 | 68 | 74 | 59 | 92 | 56 | 70 | 59 | 106 | 53 |
| OPM % | 15% | 16% | 16% | 17% | 16% | 16% | 14% | 17% | 14% | 14% | 13% | 18% | 13% |
| Other Income | -0 | 11 | 14 | 5 | 16 | 11 | 16 | 16 | 16 | 18 | 12 | 14 | 19 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 1 |
| Depreciation | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 8 | 10 | 10 | 10 | 9 |
| Profit before tax | 53 | 68 | 77 | 83 | 75 | 76 | 65 | 98 | 63 | 75 | 60 | 108 | 61 |
| Tax % | 25% | 25% | 27% | 25% | 25% | 25% | 22% | 23% | 25% | 10% | 23% | 21% | 24% |
| Net Profit | 40 | 51 | 56 | 63 | 56 | 57 | 51 | 75 | 47 | 68 | 46 | 86 | 47 |
| EPS in Rs | 30.47 | 39.00 | 43.34 | 48.39 | 43.34 | 43.74 | 39.12 | 57.69 | 36.11 | 52.35 | 35.26 | 65.80 | 35.78 |
Last Updated: August 20, 2025, 12:20 pm
Below is a detailed analysis of the quarterly data for Cera Sanitaryware Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 419.00 Cr.. The value appears to be declining and may need further review. It has decreased from 578.00 Cr. (Mar 2025) to 419.00 Cr., marking a decrease of 159.00 Cr..
- For Expenses, as of Jun 2025, the value is 366.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 472.00 Cr. (Mar 2025) to 366.00 Cr., marking a decrease of 106.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 106.00 Cr. (Mar 2025) to 53.00 Cr., marking a decrease of 53.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 13.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 5.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 108.00 Cr. (Mar 2025) to 61.00 Cr., marking a decrease of 47.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2025) to 24.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 86.00 Cr. (Mar 2025) to 47.00 Cr., marking a decrease of 39.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 35.78. The value appears to be declining and may need further review. It has decreased from 65.80 (Mar 2025) to 35.78, marking a decrease of 30.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:33 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 664 | 822 | 917 | 1,011 | 1,182 | 1,344 | 1,209 | 1,202 | 1,442 | 1,803 | 1,871 | 1,915 | 1,937 |
| Expenses | 569 | 703 | 776 | 841 | 1,014 | 1,152 | 1,045 | 1,052 | 1,220 | 1,510 | 1,577 | 1,622 | 1,649 |
| Operating Profit | 95 | 119 | 141 | 171 | 168 | 191 | 164 | 150 | 221 | 293 | 295 | 293 | 288 |
| OPM % | 14% | 14% | 15% | 17% | 14% | 14% | 14% | 12% | 15% | 16% | 16% | 15% | 15% |
| Other Income | 6 | 5 | 10 | 11 | 14 | 15 | 14 | 22 | 17 | 25 | 59 | 59 | 63 |
| Interest | 6 | 8 | 5 | 5 | 5 | 3 | 4 | 4 | 5 | 5 | 5 | 7 | 7 |
| Depreciation | 12 | 15 | 16 | 18 | 22 | 23 | 33 | 33 | 30 | 30 | 34 | 39 | 39 |
| Profit before tax | 82 | 101 | 129 | 158 | 154 | 180 | 141 | 134 | 203 | 282 | 314 | 306 | 304 |
| Tax % | 37% | 33% | 36% | 34% | 35% | 36% | 18% | 25% | 27% | 26% | 24% | 19% | |
| Net Profit | 52 | 68 | 83 | 104 | 100 | 115 | 116 | 101 | 149 | 210 | 239 | 246 | 246 |
| EPS in Rs | 41.02 | 52.02 | 64.17 | 79.94 | 77.08 | 88.46 | 89.14 | 77.89 | 114.84 | 161.20 | 183.89 | 189.51 | 189.19 |
| Dividend Payout % | 12% | 12% | 14% | 15% | 16% | 15% | 15% | 17% | 30% | 31% | 33% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 30.77% | 22.06% | 25.30% | -3.85% | 15.00% | 0.87% | -12.93% | 47.52% | 40.94% | 13.81% | 2.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | -8.71% | 3.24% | -29.15% | 18.85% | -14.13% | -13.80% | 60.46% | -6.59% | -27.13% | -10.88% |
Cera Sanitaryware Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 10% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 17% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 21% |
| 3 Years: | 6% |
| 1 Year: | -32% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 17% |
| 3 Years: | 19% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 1:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 218 | 345 | 415 | 518 | 598 | 694 | 766 | 868 | 999 | 1,163 | 1,336 | 1,344 | 1,364 |
| Borrowings | 48 | 68 | 35 | 34 | 24 | 18 | 33 | 28 | 37 | 46 | 40 | 63 | 60 |
| Other Liabilities | 181 | 224 | 290 | 302 | 320 | 371 | 320 | 381 | 385 | 441 | 443 | 427 | 383 |
| Total Liabilities | 453 | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,841 | 1,814 |
| Fixed Assets | 152 | 215 | 226 | 266 | 279 | 305 | 350 | 330 | 321 | 320 | 356 | 380 | 375 |
| CWIP | 5 | 8 | 4 | 0 | 5 | 11 | 1 | 1 | 1 | 17 | 13 | 11 | 9 |
| Investments | 12 | 48 | 67 | 119 | 139 | 212 | 262 | 513 | 567 | 669 | 807 | 702 | 712 |
| Other Assets | 284 | 374 | 449 | 475 | 525 | 561 | 512 | 440 | 539 | 649 | 649 | 749 | 718 |
| Total Assets | 453 | 644 | 747 | 861 | 949 | 1,089 | 1,126 | 1,283 | 1,427 | 1,656 | 1,825 | 1,841 | 1,814 |
Below is a detailed analysis of the balance sheet data for Cera Sanitaryware Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,364.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,344.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 20.00 Cr..
- For Borrowings, as of Sep 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 383.00 Cr.. The value appears to be improving (decreasing). It has decreased from 427.00 Cr. (Mar 2025) to 383.00 Cr., marking a decrease of 44.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,814.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,841.00 Cr. (Mar 2025) to 1,814.00 Cr., marking a decrease of 27.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 375.00 Cr.. The value appears to be declining and may need further review. It has decreased from 380.00 Cr. (Mar 2025) to 375.00 Cr., marking a decrease of 5.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 712.00 Cr.. The value appears strong and on an upward trend. It has increased from 702.00 Cr. (Mar 2025) to 712.00 Cr., marking an increase of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 718.00 Cr.. The value appears to be declining and may need further review. It has decreased from 749.00 Cr. (Mar 2025) to 718.00 Cr., marking a decrease of 31.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,814.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,841.00 Cr. (Mar 2025) to 1,814.00 Cr., marking a decrease of 27.00 Cr..
Notably, the Reserves (1,364.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 47.00 | 51.00 | 106.00 | 137.00 | 144.00 | 173.00 | 131.00 | 122.00 | 184.00 | 247.00 | 255.00 | 230.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59 | 72 | 75 | 80 | 83 | 81 | 67 | 63 | 42 | 38 | 39 | 51 |
| Inventory Days | 125 | 120 | 109 | 98 | 104 | 101 | 128 | 96 | 154 | 167 | 148 | 163 |
| Days Payable | 45 | 46 | 48 | 58 | 50 | 53 | 52 | 81 | 104 | 93 | 75 | 77 |
| Cash Conversion Cycle | 139 | 145 | 137 | 120 | 136 | 129 | 142 | 78 | 92 | 112 | 112 | 137 |
| Working Capital Days | 33 | 43 | 47 | 43 | 56 | 58 | 66 | 30 | 37 | 43 | 44 | 65 |
| ROCE % | 35% | 32% | 30% | 31% | 26% | 27% | 19% | 16% | 22% | 26% | 25% | 22% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HSBC Small Cap Fund | 338,650 | 1.27 | 210.86 | N/A | N/A | N/A |
| Canara Robeco Small Cap Fund | 304,497 | 1.43 | 189.6 | 218,823 | 2025-12-07 15:33:48 | 39.15% |
| UTI Small Cap Fund | 69,170 | 0.88 | 43.07 | N/A | N/A | N/A |
| Edelweiss Small Cap Fund | 55,965 | 0.66 | 34.85 | N/A | N/A | N/A |
| Tata India Consumer Fund | 55,691 | 1.3 | 34.68 | N/A | N/A | N/A |
| Edelweiss Large & Mid Cap Fund | 49,866 | 0.71 | 31.05 | N/A | N/A | N/A |
| Bandhan Flexi Cap Fund | 40,002 | 0.33 | 24.91 | N/A | N/A | N/A |
| Tata Housing Opportunities Fund | 19,804 | 2.29 | 12.33 | N/A | N/A | N/A |
| Taurus Ethical Fund | 5,983 | 1.05 | 3.72 | N/A | N/A | N/A |
| ITI Value Fund | 5,755 | 1.04 | 3.58 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 190.40 | 183.76 | 161.01 | 116.18 | 77.48 |
| Diluted EPS (Rs.) | 190.40 | 183.76 | 161.01 | 116.18 | 77.48 |
| Cash EPS (Rs.) | 224.36 | 213.65 | 187.35 | 142.51 | 107.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1049.48 | 1044.56 | 909.79 | 791.48 | 679.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1049.48 | 1044.56 | 909.79 | 791.48 | 679.28 |
| Revenue From Operations / Share (Rs.) | 1493.42 | 1445.06 | 1386.69 | 1111.68 | 941.37 |
| PBDIT / Share (Rs.) | 279.40 | 278.93 | 252.61 | 194.05 | 140.87 |
| PBIT / Share (Rs.) | 247.87 | 250.83 | 227.54 | 169.13 | 110.45 |
| PBT / Share (Rs.) | 240.90 | 245.16 | 219.04 | 160.66 | 102.97 |
| Net Profit / Share (Rs.) | 192.83 | 185.55 | 162.27 | 117.60 | 76.82 |
| NP After MI And SOA / Share (Rs.) | 191.10 | 183.77 | 161.01 | 116.18 | 77.48 |
| PBDIT Margin (%) | 18.70 | 19.30 | 18.21 | 17.45 | 14.96 |
| PBIT Margin (%) | 16.59 | 17.35 | 16.40 | 15.21 | 11.73 |
| PBT Margin (%) | 16.13 | 16.96 | 15.79 | 14.45 | 10.93 |
| Net Profit Margin (%) | 12.91 | 12.84 | 11.70 | 10.57 | 8.16 |
| NP After MI And SOA Margin (%) | 12.79 | 12.71 | 11.61 | 10.45 | 8.23 |
| Return on Networth / Equity (%) | 18.20 | 17.75 | 17.85 | 14.88 | 11.56 |
| Return on Capital Employeed (%) | 21.43 | 22.26 | 23.06 | 19.66 | 14.29 |
| Return On Assets (%) | 13.23 | 12.95 | 12.48 | 9.73 | 7.31 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.02 | 0.02 | 0.05 |
| Asset Turnover Ratio (%) | 1.04 | 1.07 | 1.12 | 1.03 | 0.96 |
| Current Ratio (X) | 3.82 | 3.74 | 3.24 | 2.68 | 2.42 |
| Quick Ratio (X) | 2.72 | 2.79 | 2.27 | 2.01 | 1.88 |
| Inventory Turnover Ratio (X) | 0.72 | 0.67 | 0.76 | 0.72 | 0.41 |
| Dividend Payout Ratio (NP) (%) | 31.65 | 27.20 | 21.73 | 11.18 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 27.17 | 23.59 | 18.80 | 9.21 | 0.00 |
| Earning Retention Ratio (%) | 68.35 | 72.80 | 78.27 | 88.82 | 0.00 |
| Cash Earning Retention Ratio (%) | 72.83 | 76.41 | 81.20 | 90.79 | 0.00 |
| Interest Coverage Ratio (X) | 48.10 | 62.32 | 54.32 | 47.79 | 18.83 |
| Interest Coverage Ratio (Post Tax) (X) | 34.40 | 42.72 | 36.72 | 31.05 | 11.27 |
| Enterprise Value (Cr.) | 7272.80 | 8811.02 | 8314.10 | 6496.10 | 5152.10 |
| EV / Net Operating Revenue (X) | 3.78 | 4.69 | 4.61 | 4.49 | 4.21 |
| EV / EBITDA (X) | 20.18 | 24.29 | 25.31 | 25.74 | 28.12 |
| MarketCap / Net Operating Revenue (X) | 3.78 | 4.69 | 4.60 | 4.47 | 4.15 |
| Retention Ratios (%) | 68.34 | 72.79 | 78.26 | 88.81 | 0.00 |
| Price / BV (X) | 5.37 | 6.55 | 7.08 | 6.37 | 5.83 |
| Price / Net Operating Revenue (X) | 3.78 | 4.69 | 4.60 | 4.47 | 4.15 |
| EarningsYield | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
After reviewing the key financial ratios for Cera Sanitaryware Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 190.40. This value is within the healthy range. It has increased from 183.76 (Mar 24) to 190.40, marking an increase of 6.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 190.40. This value is within the healthy range. It has increased from 183.76 (Mar 24) to 190.40, marking an increase of 6.64.
- For Cash EPS (Rs.), as of Mar 25, the value is 224.36. This value is within the healthy range. It has increased from 213.65 (Mar 24) to 224.36, marking an increase of 10.71.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,049.48. It has increased from 1,044.56 (Mar 24) to 1,049.48, marking an increase of 4.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,049.48. It has increased from 1,044.56 (Mar 24) to 1,049.48, marking an increase of 4.92.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,493.42. It has increased from 1,445.06 (Mar 24) to 1,493.42, marking an increase of 48.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 279.40. This value is within the healthy range. It has increased from 278.93 (Mar 24) to 279.40, marking an increase of 0.47.
- For PBIT / Share (Rs.), as of Mar 25, the value is 247.87. This value is within the healthy range. It has decreased from 250.83 (Mar 24) to 247.87, marking a decrease of 2.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 240.90. This value is within the healthy range. It has decreased from 245.16 (Mar 24) to 240.90, marking a decrease of 4.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 192.83. This value is within the healthy range. It has increased from 185.55 (Mar 24) to 192.83, marking an increase of 7.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 191.10. This value is within the healthy range. It has increased from 183.77 (Mar 24) to 191.10, marking an increase of 7.33.
- For PBDIT Margin (%), as of Mar 25, the value is 18.70. This value is within the healthy range. It has decreased from 19.30 (Mar 24) to 18.70, marking a decrease of 0.60.
- For PBIT Margin (%), as of Mar 25, the value is 16.59. This value is within the healthy range. It has decreased from 17.35 (Mar 24) to 16.59, marking a decrease of 0.76.
- For PBT Margin (%), as of Mar 25, the value is 16.13. This value is within the healthy range. It has decreased from 16.96 (Mar 24) to 16.13, marking a decrease of 0.83.
- For Net Profit Margin (%), as of Mar 25, the value is 12.91. This value exceeds the healthy maximum of 10. It has increased from 12.84 (Mar 24) to 12.91, marking an increase of 0.07.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.79. This value is within the healthy range. It has increased from 12.71 (Mar 24) to 12.79, marking an increase of 0.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.20. This value is within the healthy range. It has increased from 17.75 (Mar 24) to 18.20, marking an increase of 0.45.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.43. This value is within the healthy range. It has decreased from 22.26 (Mar 24) to 21.43, marking a decrease of 0.83.
- For Return On Assets (%), as of Mar 25, the value is 13.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 13.23, marking an increase of 0.28.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.04. It has decreased from 1.07 (Mar 24) to 1.04, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has increased from 3.74 (Mar 24) to 3.82, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 2.72. This value exceeds the healthy maximum of 2. It has decreased from 2.79 (Mar 24) to 2.72, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 4. It has increased from 0.67 (Mar 24) to 0.72, marking an increase of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.65. This value is within the healthy range. It has increased from 27.20 (Mar 24) to 31.65, marking an increase of 4.45.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.17. This value is within the healthy range. It has increased from 23.59 (Mar 24) to 27.17, marking an increase of 3.58.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.35. This value is within the healthy range. It has decreased from 72.80 (Mar 24) to 68.35, marking a decrease of 4.45.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.83. This value exceeds the healthy maximum of 70. It has decreased from 76.41 (Mar 24) to 72.83, marking a decrease of 3.58.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.10. This value is within the healthy range. It has decreased from 62.32 (Mar 24) to 48.10, marking a decrease of 14.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 34.40. This value is within the healthy range. It has decreased from 42.72 (Mar 24) to 34.40, marking a decrease of 8.32.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,272.80. It has decreased from 8,811.02 (Mar 24) to 7,272.80, marking a decrease of 1,538.22.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
- For EV / EBITDA (X), as of Mar 25, the value is 20.18. This value exceeds the healthy maximum of 15. It has decreased from 24.29 (Mar 24) to 20.18, marking a decrease of 4.11.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
- For Retention Ratios (%), as of Mar 25, the value is 68.34. This value is within the healthy range. It has decreased from 72.79 (Mar 24) to 68.34, marking a decrease of 4.45.
- For Price / BV (X), as of Mar 25, the value is 5.37. This value exceeds the healthy maximum of 3. It has decreased from 6.55 (Mar 24) to 5.37, marking a decrease of 1.18.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.78. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 24) to 3.78, marking a decrease of 0.91.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cera Sanitaryware Ltd:
- Net Profit Margin: 12.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.43% (Industry Average ROCE: 12.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.2% (Industry Average ROE: 13.16%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 34.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 28.9 (Industry average Stock P/E: 36.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Ceramics/Tiles/Sanitaryware | 9, GIDC Industrial Estate, Mehsana Dist. Gujarat 382715 | kadi@cera-india.com http://www.cera-india.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vikram Somany | Chairman & Managing Director |
| Mrs. Deepshikha Khaitan | Vice Chairman & Jt Manag. Dir. |
| Mr. Anupam Gupta | Executive Director -Technical |
| Mr. Surendra Singh Baid | Independent Director |
| Ms. Akriti Jain | Independent Director |
| Mr. Ravi Bhamidipaty | Independent Director |
| Mr. Anandh Sundar | Independent Director |
FAQ
What is the intrinsic value of Cera Sanitaryware Ltd?
Cera Sanitaryware Ltd's intrinsic value (as of 12 December 2025) is 4552.83 which is 13.74% lower the current market price of 5,278.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,807 Cr. market cap, FY2025-2026 high/low of 7,880/5,060, reserves of ₹1,364 Cr, and liabilities of 1,814 Cr.
What is the Market Cap of Cera Sanitaryware Ltd?
The Market Cap of Cera Sanitaryware Ltd is 6,807 Cr..
What is the current Stock Price of Cera Sanitaryware Ltd as on 12 December 2025?
The current stock price of Cera Sanitaryware Ltd as on 12 December 2025 is 5,278.
What is the High / Low of Cera Sanitaryware Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cera Sanitaryware Ltd stocks is 7,880/5,060.
What is the Stock P/E of Cera Sanitaryware Ltd?
The Stock P/E of Cera Sanitaryware Ltd is 28.9.
What is the Book Value of Cera Sanitaryware Ltd?
The Book Value of Cera Sanitaryware Ltd is 1,063.
What is the Dividend Yield of Cera Sanitaryware Ltd?
The Dividend Yield of Cera Sanitaryware Ltd is 1.23 %.
What is the ROCE of Cera Sanitaryware Ltd?
The ROCE of Cera Sanitaryware Ltd is 22.4 %.
What is the ROE of Cera Sanitaryware Ltd?
The ROE of Cera Sanitaryware Ltd is 18.3 %.
What is the Face Value of Cera Sanitaryware Ltd?
The Face Value of Cera Sanitaryware Ltd is 5.00.